Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Shire's Takhzyro scores EU approval in rare genetic disorder hereditary angioedema

pharmafileDecember 04, 2018

Tag: HAE , Takhzyro , Shire

PharmaSources Customer Service